Precigen Inc

Healthcare · Biotechnology

7.60$ -2.5% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Precigen Inc (PGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 170 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PGEN
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	1,006	949	916	934	898	847	896	825	980	716	710	655	605	456	405	362	336	315	407	403	377	360	336	321	259	216	242	208	191	151	135	73	83	145	129	102	171	157	139	170
Current Assets	316	315	282	234	180	154	188	148	310	285	232	183	157	235	189	173	151	149	144	157	153	157	155	165	163	118	138	106	93	69	50	24	35	102	85	63	130	115	102	134
Cash	70	63	70	64	64	68	120	78	82	103	107	58	44	66	38	47	28	52	27	36	42	36	40	44	92	4.9	9.7	17	10	7.6	17	9.3	25	30	6.1	14	14	30	7.5	16
Cash & Short-Term Investments	237	237	205	157	109	80	124	81	247	223	182	126	106	75	149	133	113	100	106	115	114	109	112	115	154	56	104	88	74	63	45	20	29	98	80	60	121	98	56	38
Receivables	42	42	43	44	38	40	31	34	30	28	25	34	25	26	20	24	19	20	21	27	21	2.0	25	1.9	2.5	14	16	14	14	1.6	1.2	1.0	0.7	1.2	1.1	0.6	1.1	4.4	27	72
Inventory	22	21	19	19	18	20	20	20	18	21	20	18	17	16	15	13	10	11	11	11	9.9	0.3	13	0.2	0.2	0.3	14	–	–	0.0	0.0	–	–	0.0	–	–	3.1	9.6	15	20
Property, Plant & Equipment	–	65	68	93	103	113	119	119	123	129	136	120	123	61	60	47	64	35	34	45	45	45	34	17	7.6	7.3	6.9	6.6	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	160	157	158	165	167	153	155	152	151	150	151	150	148	64	64	54	54	54	54	54	54	38	54	37	37	37	37	37	37	27	27	25	25	19	19	15	15	15	15	15
Intangible Assets	239	226	223	240	241	233	232	219	213	129	126	113	107	68	65	65	65	65	61	60	57	52	51	46	42	44	44	43	40	41	39	5.1	4.8	4.5	4.1	3.8	3.5	3.2	2.9	2.5
Total Liabilities	397	380	366	362	345	300	324	258	425	337	375	376	376	384	317	312	278	247	232	243	246	253	262	266	117	90	57	41	43	33	38	30	28	107	143	139	129	136	118	127
Current Liabilities	101	95	91	96	88	80	87	83	92	62	59	52	82	123	71	64	31	42	25	29	29	35	26	30	105	79	47	31	33	23	29	23	21	22	24	23	32	37	21	29
Short-Term Debt	1.0	1.2	0.8	0.7	0.7	0.7	0.8	1.1	0.7	2.5	5.6	5.7	38	36	37	41	9.6	3.0	5.7	2.3	4.3	1.4	3.5	1.0	83	44	15	1.4	1.2	1.2	1.3	1.3	1.0	1.0	0.9	0.9	1.1	1.1	1.1	1.1
Accounts Payable	7.9	8.5	8.0	8.2	7.9	8.7	7.8	8.4	8.5	12	13	8.6	7.4	5.5	4.9	3.7	4.2	4.6	4.3	4.9	3.6	3.1	4.4	2.7	4.2	4.1	3.8	2.5	2.4	1.7	4.7	4.8	4.3	3.5	3.1	3.9	6.3	12	2.6	5.3
Long-Term Debt	–	7.6	7.6	7.7	7.7	7.5	7.4	7.3	183	211	214	212	184	186	189	191	194	172	174	177	180	183	201	199	–	–	–	–	–	–	–	–	–	–	–	–	93	93	94	94
Shareholders' Equity	600	560	529	551	534	534	553	550	539	363	313	279	228	72	87	50	59	67	175	159	131	107	74	56	143	126	184	166	148	118	97	43	55	39	-14	-37	42	21	20	44
Retained Earnings	-685	-729	-762	-781	-821	-848	-930	-933	-990	-1,331	-1,391	-1,430	-1,484	-1,653	-1,709	-1,752	-1,782	-1,823	-1,841	-1,861	-1,891	-1,916	-1,916	-1,934	-1,846	-1,869	-1,891	-1,912	-1,931	-1,964	-1,988	-2,047	-2,071	-2,091	-2,145	-2,172	-2,318	-2,341	-2,349	-2,329
Shares Outstanding	118	119	119	120	121	121	128	129	130	132	153	154	155	155	160	164	166	178	193	199	199	199	200	200	201	208	230	248	249	249	249	252	276	293	294	296	296	313	313	414

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings